These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 135666)

  • 1. Combination chemotherapy with adriamycin and streptozotocin. I. Clinical results in patients with advanced sarcoma.
    Chang P; Wiernik PH
    Clin Pharmacol Ther; 1976 Nov; 20(5):605-10. PubMed ID: 135666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with adriamycin and streptozotocin. II. Clincopharmacologic correlation of augmented adriamycin toxicity caused by streptozotocin.
    Chang P; Riggs CE; Scheerer MT; Wiernik PH; Bachur NR
    Clin Pharmacol Ther; 1976 Nov; 20(5):611-6. PubMed ID: 135667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin.
    Levi JA; Wiernik PH; Diggs CH
    Med Pediatr Oncol; 1977; 3(1):33-40. PubMed ID: 65727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial adriamycin (NSC 123127) in advanced sarcomas.
    Creagan ET; Hahn RG; Ahmann DL; Bisel HF
    Oncology; 1977; 34(2):90-1. PubMed ID: 896123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
    Moertel CG; Douglas HO; Hanley J; Carbone PP
    Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new combination chemotherapy for resistant Hodgkin disease.
    Vinciguerra V; Coleman M; Jarowski CI; Degnan TJ; Silver RT
    JAMA; 1977 Jan; 237(1):33-5. PubMed ID: 62854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group Study.
    Vaughn CB; Green SJ; O'Bryan R; Reed M; Grozea PN; Fletcher WS; Green JB; Metch B; Oishi N
    Med Pediatr Oncol; 1988; 16(5):312-9. PubMed ID: 3054453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.
    Omura GA; Major FJ; Blessing JA; Sedlacek TV; Thigpen JT; Creasman WT; Zaino RJ
    Cancer; 1983 Aug; 52(4):626-32. PubMed ID: 6344983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of adriamycin and dibromodulcitol in metastatic breast carcinoma.
    Tormey DC; Simon R; Falkson G; Bull J; Band P; Perlin E; Blom J
    Cancer Res; 1977 Feb; 37(2):529-34. PubMed ID: 832277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma.
    Schoenfeld DA; Rosenbaum C; Horton J; Wolter JM; Falkson G; DeConti RC
    Cancer; 1982 Dec; 50(12):2757-62. PubMed ID: 7139566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Santoro A; Tursz T; Mouridsen H; Verweij J; Steward W; Somers R; Buesa J; Casali P; Spooner D; Rankin E
    J Clin Oncol; 1995 Jul; 13(7):1537-45. PubMed ID: 7602342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group study.
    Rivkin SE; Gottlieb JA; Thigpen T; El Mawla NG; Saiki J; Dixon DO
    Cancer; 1980 Aug; 46(3):446-51. PubMed ID: 7397620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary trial of combination therapy with adriamycin and radiation in sarcomas and other malignant tumors.
    Sordillo PP; Magill GB; Schauer PK; Vikram B; Kim JH; Hilaris BS
    J Surg Oncol; 1982 Sep; 21(1):23-6. PubMed ID: 7109633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
    Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin.
    Morstyn G; Ihde DC; Eddy JL; Bunn PA; Cohen MH; Minna JD
    Am J Clin Oncol; 1983 Oct; 6(5):547-51. PubMed ID: 6310986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
    Borden EC; Amato DA; Rosenbaum C; Enterline HT; Shiraki MJ; Creech RH; Lerner HJ; Carbone PP
    J Clin Oncol; 1987 Jun; 5(6):840-50. PubMed ID: 3585441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study.
    Bramwell VH; Mouridsen HT; Mulder JH; Somers R; Van Oosterom AT; Santoro A; Thomas D; Sylvester R; Markham D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1097-104. PubMed ID: 6352280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.